News summary

Dual blockade of adenosine A2A and A2B receptors is required to reverse NECA-induced immunosuppression in human macrophages: Implications for cancer immunotherapy

Source: Frontiers - Health • Published: 14 Sept 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

How adenosine analogues reshape human macrophages and how dual A2A/A2B receptor blockade could therapeutically reverse that suppression — a research article preview inviting clinicians and scientists.

Dual blockade of adenosine A2A and A2B receptors is required to reverse NECA-induced immunosuppression in human macrophages: Implications for cancer immunotherapy
Key Takeaways
  • NECA-conditioned human monocyte-derived macrophages showed reduced IL-12, IL-23, IL-6, and TNFα production.
  • These NECA-treated macrophages increased VEGF-A and IL-10 expression and impaired T cell IFNγ responses.
  • Simultaneous pharmacologic blockade of both A2A and A2B receptors restored macrophage polarization and rescued T cell function.
Read the full article at Frontiers - Health

Continue exploring

Recommended MoL Picks

MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.